EUDA Health (NASDAQ:EUDA) Corporation (NASDAQ:EUDA) is a clinical-stage healthcare company dedicated to developing digital therapeutics and precision medicine solutions for chronic metabolic and autoimmune conditions. Founded in 2019 as BioAutoimmune and rebranded in 2023 to reflect its expanded mission, the company integrates advanced biomarker analysis, artificial intelligence, and behavioral science to create personalized, non‐pharmacological interventions. EUDA Health’s research is focused on conditions such as obesity, type 2 diabetes, depression and various autoimmune disorders.
The company’s product pipeline features a suite of digital therapeutic platforms accessible via mobile and web-based applications. These platforms continuously collect data from wearable devices, laboratory tests, and patient-reported outcomes, enabling adaptive treatment protocols that evolve with each user’s progress. EUDA Health combines nutritional guidance, lifestyle coaching and digital monitoring in its proprietary clinical programs, aiming to deliver sustained health improvements and reduce reliance on traditional drug therapies.
Operating primarily in the United States, EUDA Health collaborates with healthcare systems, managed care organizations and telehealth providers to deploy its digital therapeutics in both clinical trial settings and real-world environments. Strategic partnerships with major medical groups enhance the company’s ability to validate its solutions and expand patient access. EUDA Health is well positioned to benefit from the healthcare industry’s shift toward value-based care and growing interest in evidence-based, technology-driven treatment modalities.
Under the leadership of CEO Rafael Buenrostro, EUDA Health’s executive team brings together expertise in digital health innovation, clinical development and biotech commercialization. The team includes seasoned professionals in data science, regulatory affairs and healthcare delivery, all working toward scalable adoption of the company’s digital therapeutics. By pursuing regulatory clearances and ongoing clinical validation, EUDA Health aims to establish new standards in personalized healthcare and improve outcomes for patients managing chronic diseases.
